Article(id=1329869938552058760, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869930205393694, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.04.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1661961600000, receivedDateStr=2022-09-01, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794995301139, onlineDateStr=2026-11-18, pubDate=1681056000000, pubDateStr=2023-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794995301139, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794995301139, creator=13701087609, updateTime=1794995301139, updator=13701087609, issue=Issue{id=1329869930205393694, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='4', pageStart='301', pageEnd='396', issueExtLink='null', onlineDate='null', pubDate='1681056000000', pubDateStr='2023-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794995299149, creator='13701087609', updateTime=1794995858179, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329872275278508469, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869930205393694, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329872275278508470, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869930205393694, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=384, endPage=396, ext={EN=ArticleExt(id=1329869938749191049, articleId=1329869938552058760, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress of drugs for acne approved by FDA recently, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Acne is a chronic inflammatory skin disease that mainly occurs in a large number of adolescents, with a wide age distribution and a long duration. If the treatment is not promptly or the effect is not ideal, it will have a serious negative impact on mental health and quality of life. In recent years, new drugs and modified new drugs for acne have been approved and have improved the efficacy of acne treatment, reduced the occurrence of adverse reactions, and enriched the choice of clinical drugs. Based on the pathogenesis of acne, the classification of treatment and classical therapeutic drugs, this article summarized the new acne drugs approved by FDA and their results of the key clinical trials in the past decade, introduced the current situation of the drugs in clinical stage at home and abroad, and finally discussed the challenges of related drugs development and issues requiring attention, to provide a reference for clinicians and new drug researchers.
, authors=Dongyu WU, Xuyu CHAI
*, authorsList=Dongyu WU, Xuyu CHAI, authorCompany=null, correspAuthors=Xuyu CHAI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329869938963100554, articleId=1329869938552058760, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=FDA新批准的痤疮药物及研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
痤疮(acne)是一种多发于青少年的慢性炎症性皮肤病,患病人数多、年龄宽以及持续时间长,如治疗不及时或效果不理想,会给患者的心理健康和生活质量带来严重的负面影响。近年来,痤疮类创新药物和改良型新药的不断获批使用,提高了疾病治疗的效果,减少了不良反应的发生,同时丰富了临床用药的选择。文章从痤疮发病机制、分型论治和经典治疗药物入手,总结近年FDA批准上市的痤疮新药及其关键临床研究的结果,介绍国内外目前正处于临床研究阶段的药物情况,对于相关药物开发的挑战和需要关注的问题进行讨论,以期为临床医生和新药研发者提供参考。
, authors=吴东宇, 柴旭煜
*, authorsList=吴东宇, 柴旭煜, authorCompany=null, correspAuthors=柴旭煜, authorNote=
吴东宇,硕士研究生,研究方向:局部药物递送及评价。
, correspAuthorsNote=
柴旭煜,博士,副研究员,研究方向:制剂新技术及产业化。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=VLkdoBtJ7Ol+WOd9DOIn8Q==, magXml=3hHV/dMC2l2/J97u+nzkkg==, pdfUrl=null, pdf=29L592EpnPmj93eCeg5GCQ==, pdfFileSize=1656174, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=pDZLjbAA6/vuX+VkWkS/Gg==, mapNumber=null, fund=null)}, authors=[Author(id=1329869939210564495, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869939298644881, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, authorId=1329869939210564495, language=EN, stringName=Dongyu WU, firstName=Dongyu, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869939374142354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, authorId=1329869939210564495, language=CN, stringName=吴东宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio={"content":"
吴东宇,硕士研究生,研究方向:局部药物递送及评价。
"}, bioImg=null, bioContent=
吴东宇,硕士研究生,研究方向:局部药物递送及评价。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869939143455627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, xref=null, ext=[AuthorCompanyExt(id=1329869939147649932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, companyId=1329869939143455627, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1329869939156038541, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, companyId=1329869939143455627, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1329869939424474004, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869939504165782, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, authorId=1329869939424474004, language=EN, stringName=Xuyu CHAI, firstName=Xuyu, middleName=null, lastName=CHAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869939558691735, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, authorId=1329869939424474004, language=CN, stringName=柴旭煜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869939143455627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, xref=null, ext=[AuthorCompanyExt(id=1329869939147649932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, companyId=1329869939143455627, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1329869939156038541, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, companyId=1329869939143455627, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])])], keywords=[Keyword(id=1329869939659355032, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, language=EN, orderNo=1, keyword=acne), Keyword(id=1329869939713880985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, language=EN, orderNo=2, keyword=new drug), Keyword(id=1329869939772601242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, language=EN, orderNo=3, keyword=modified new drug), Keyword(id=1329869939822932891, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, language=EN, orderNo=4, keyword=topical semisolid dosage forms), Keyword(id=1329869939877458844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, language=CN, orderNo=1, keyword=痤疮), Keyword(id=1329869939940373405, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, language=CN, orderNo=2, keyword=新药), Keyword(id=1329869940003287966, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, language=CN, orderNo=3, keyword=改良型新药), Keyword(id=1329869940062008223, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, language=CN, orderNo=4, keyword=局部外用半固体制剂)], refs=[Reference(id=1329869940141700000, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=石永进, 叶晓成. 口服与外用痤疮治疗药物市场分析[J]. 世界临床药物, 2009, 30(5): 312-316., articleTitle=null, refAbstract=null), Reference(id=1329869940208808865, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=鞠强. 中国痤疮治疗指南(2019修订版)[J]. 临床皮肤科杂志, 2019, 48(9): 583-588., articleTitle=null, refAbstract=null), Reference(id=1329869940271723426, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Shen Y, Wang T, Zhou C,
et al. Prevalence of acne vulgaris in Chinese adolescents and adults: a community-based study of 17,345 subjects in six cities[J]. Acta Derm Venereol, 2012, 92(1): 40-44., articleTitle=null, refAbstract=null), Reference(id=1329869940338832291, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Leyden JJ. New understandings of the pathogenesis of acne[J]. J Am Acad Dermatol, 1995, 32(5 Pt 3): S15-S25., articleTitle=null, refAbstract=null), Reference(id=1329869940401746852, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Knutsen-Larson S, Dawson AL, Dunnick CA,
et al. Acne vulgaris: pathogenesis, treatment, and needs assessment[J]. Dermatol Clin, 2012, 30(1): 99-106., articleTitle=null, refAbstract=null), Reference(id=1329869940477244325, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Kurokawa I, Danby FW, Ju Q,
et al. New developments in our understanding of acne pathogenesis and treatment[J]. Exp Dermatol, 2009, 18(10): 821-832., articleTitle=null, refAbstract=null), Reference(id=1329869940540158886, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=He L, Wu WJ, Yang JK,
et al. Two new susceptibility loci 1q24.2 and 11p11.2 confer risk to severe acne[J]. Nat Commun, 2014, 5: 2870., articleTitle=null, refAbstract=null), Reference(id=1329869940607267751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Titus S, Hodge J. Diagnosis and treatment of acne[J]. Am Fam Physician, 2012, 86(8): 734-740., articleTitle=null, refAbstract=null), Reference(id=1329869940670182312, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Langley RG, Feldman SR, Nyirady J,
et al. The 5-point Investigator's Global Assessment (IGA) Scale: a modified tool for evaluating plaque psoriasis severity in clinical trials[J]. J Dermatolog Treat, 2015, 26(1): 23-31., articleTitle=null, refAbstract=null), Reference(id=1329869940758262697, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=靳培英. 痤疮的分型论治[J]. 中华皮肤科杂志, 2002, (1): 66-68., articleTitle=null, refAbstract=null), Reference(id=1329869940837954474, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Krautheim A, Gollnick HP. Acne: topical treatment[J]. Clin Dermatol, 2004, 22(5): 398-407., articleTitle=null, refAbstract=null), Reference(id=1329869940905063339, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Rathi SK. Acne vulgaris treatment: the current scenario[J]. Indian J Dermatol, 2011, 56(1): 7-13., articleTitle=null, refAbstract=null), Reference(id=1329869940972172204, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Jain S. Topical tretinoin or adapalene in acne vulgaris: an overview[J]. J Dermatolog Treat, 2004, 15(4): 200-207., articleTitle=null, refAbstract=null), Reference(id=1329869941085418413, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Balak DMW. Topical trifarotene: a new retinoid[J]. Br J Dermatol, 2018, 179(2): 231-232., articleTitle=null, refAbstract=null), Reference(id=1329869941169304494, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Sardana K, Sehgal VN. Retinoids: fascinating up-and-coming scenario[J]. J Dermatol, 2003, 30(5): 355-380., articleTitle=null, refAbstract=null), Reference(id=1329869941248996271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Griffiths CE. Retinoids and vitamin D analogues: action on nuclear transcription[J]. Hosp Med, 1998, 59(1): 12-16., articleTitle=null, refAbstract=null), Reference(id=1329869941307716528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Roos T. 'Retinoids '97': the meeting of the European retinoid research group (ERRG) 1997[J]. Skin Pharmacol Appl Skin Physiol, 1998, 11(3): 166-169., articleTitle=null, refAbstract=null), Reference(id=1329869941379019697, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Scott LJ. Trifarotene: First Approval[J]. Drugs, 2019, 79(17): 1905-1909., articleTitle=null, refAbstract=null), Reference(id=1329869941437739954, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=冯素英, 林麟, 靳培英. 维A酸类药的临床应用、不良反应及对策[J]. 中华皮肤科杂志, 2003, (9): 62-64., articleTitle=null, refAbstract=null), Reference(id=1329869941492265907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Seubert S, Seubert A, Ippen H. Penetration of benzoyl peroxide in the skin[J]. Hautarzt, 1984, 35(9): 455-458., articleTitle=null, refAbstract=null), Reference(id=1329869941550986164, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Taylor GA, Shalita AR. Benzoyl peroxide-based combination therapies for acne vulgaris[J]. Am J Clin Dermatol, 2004, 5(4): 261-265., articleTitle=null, refAbstract=null), Reference(id=1329869941634872245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Waller JM, Dreher F, Behnam S,
et al. 'Keratolytic' properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man[J]. Skin Pharmacol Physiol, 2006, 19(5): 283-289., articleTitle=null, refAbstract=null), Reference(id=1329869941697786806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Lookingbill DP, Chalker DK, Lindholm JS,
et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations[J]. J Am Acad Dermatol, 1997, 37(4): 590-595., articleTitle=null, refAbstract=null), Reference(id=1329869941773284279, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Mohd Nor NH, Aziz Z. A systematic review of benzoyl peroxide for acne vulgaris[J]. J Dermatolog Treat, 2013, 24(5): 377-386., articleTitle=null, refAbstract=null), Reference(id=1329869941827810232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Farrah G, Tan E. The use of oral antibiotics in treating acne vulgaris: a new approach[J]. Dermatol Ther, 2016, 29(5): 377-384., articleTitle=null, refAbstract=null), Reference(id=1329869941882336185, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Dreno B, Thiboutot D, Gollnick H,
et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne[J]. Eur J Dermatol, 2014, 24(3): 330-334., articleTitle=null, refAbstract=null), Reference(id=1329869941945250746, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Zaenglein AL, Pathy AL, Schlosser BJ,
et al. Guidelines of care for the management of acne vulgaris[J]. J Am Acad Dermatol, 2016, 74(5): 945-973., articleTitle=null, refAbstract=null), Reference(id=1329869941999776699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Sinnott SJ, Bhate K, Margolis DJ,
et al. Antibiotics and acne: an emerging iceberg of antibiotic resistance?[J]. Br J Dermatol, 2016, 175(6): 1127-1128., articleTitle=null, refAbstract=null), Reference(id=1329869942079468476, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Patel M, Bowe WP, Heughebaert C,
et al. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review[J]. J Drugs Dermatol, 2010, 9(6): 655-664., articleTitle=null, refAbstract=null), Reference(id=1329869942142383037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Bausch Health. ALTRENO
®(tretinoin) lotion 0.05% for topical use: US prescribing information[EB/OL]. (2018-08-23) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/209353Orig1s000Lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869942196908990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Tyring SK, Kircik L, Pariser DM,
et al. The effects of once-daily tretinoin 0.05% lotion on quality of life in patients with moderate-to-severe acne vulgaris[J]. Am J Clin Dermatol, 2020, 21(6): 891-899., articleTitle=null, refAbstract=null), Reference(id=1329869942268212159, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Tyring SK, Kircik LH, Pariser DM,
et al. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of efficacy and safety in patients aged 9 years and older[J]. J Drugs Dermatol, 2018, 17(10): 1084-1091., articleTitle=null, refAbstract=null), Reference(id=1329869942331126720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Bausch Health. ARAZLO
®(tazarotene) lotion 0.045% for topical use: US prescribing information[EB/OL]. (2019-12-18) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211882Orig1s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869942394041281, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Tang-Liu DD, Matsumoto RM, Usansky JI. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis[J]. Clin Pharmacokinet, 1999, 37(4): 273-287., articleTitle=null, refAbstract=null), Reference(id=1329869942465344450, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Nagpal S, Athanikar J, Chandraratna RA. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha[J]. J Biol Chem, 1995, 270(2): 923-927., articleTitle=null, refAbstract=null), Reference(id=1329869942532453315, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanghetti E, Werschler W, Lain T,
et al. Tazarotene 0.045% lotion for once-daily treatment of moderate-to-severe acne vulgaris: results from two phase 3 trials[J]. J Drugs Dermatol, 2020, 19(1): 70-77., articleTitle=null, refAbstract=null), Reference(id=1329869942603756484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanghetti EA, Stein Gold L, Del Rosso JQ,
et al. Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology[J]. J Dermatolog Treat, 2021, 32(4): 391-398., articleTitle=null, refAbstract=null), Reference(id=1329869942666671045, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Kircik L, Gold L, Beer K,
et al. Once-daily polymeric tazarotene 0.045% lotion for moderate-to-severe acne: pooled phase 3 analysis by sex[J]. J Drugs Dermatol, 2020, 19(8): 777-783., articleTitle=null, refAbstract=null), Reference(id=1329869942725391302, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Galderma. AKLIEF
®(trifarotene) cream 0.005% for topical use: US prescribing information[EB/OL]. (2019-10-04) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211527Orig1s000Lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869942788305863, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Deruiter J, Holston PL. Trifarotene (Aklief, Galderma)[J]. US Pharm, 2020, 45(10): 26-33., articleTitle=null, refAbstract=null), Reference(id=1329869942847026120, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Kassir M, Karagaiah P, Sonthalia S,
et al. Selective RAR agonists for acne vulgaris: a narrative review[J]. J Cosmet Dermatol, 2020, 19(6): 1278-1283., articleTitle=null, refAbstract=null), Reference(id=1329869942993826761, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Tan J, Thiboutot D, Popp G,
et al. Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne[J]. J Am Acad Dermatol, 2019, 80(6): 1691-1699., articleTitle=null, refAbstract=null), Reference(id=1329869943052547018, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Blume-Peytavi U, Fowler J, Kemény L,
et al. Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne[J]. J Eur Acad Dermatol, 2020, 34(1): 166-173., articleTitle=null, refAbstract=null), Reference(id=1329869943102878667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Kalabalik-Hoganson J, Frey KM, Ozdener-Poyraz AE,
et al. Clascoterone: a novel topical androgen receptor inhibitor for the treatment of acne[J]. Ann Pharmacother, 2021, 55(10): 1290-1296., articleTitle=null, refAbstract=null), Reference(id=1329869943169987532, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Dhillon S. Clascoterone: first approval[J]. Drugs, 2020, 80(16): 1745-1750., articleTitle=null, refAbstract=null), Reference(id=1329869943237096397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Hebert A, Thiboutot D, Stein Gold L,
et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne[J]. J Am Med Assoc Dermatology, 2020, 156(6): 621., articleTitle=null, refAbstract=null), Reference(id=1329869943320982479, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun Pharma. WINLEVI
®(clascoterone) cream 1% for topical use: US prescribing information[EB/OL]. (2020-08-26) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213433Orig1s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869943379702736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Sol-Gel Technologies. Twyneo
®(tretinoin and benzoyl peroxide) cream 0.1%/3% for topical use: US prescribing information[EB/OL]. (2021-07-26) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214902s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869943442617297, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Toledano O, Bar-simantov H, Sertchook H,
et al. Core stabilized microcapsules, method of their preparation and use thereof: US, 10653899[P]. 2020-05-19., articleTitle=null, refAbstract=null), Reference(id=1329869943497143250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=Bausch Health. Retin-A micro (tretinoin) gel microsphere 0.1%, 0.08% and 0.04% for topical use[EB/OL]. (2014-01-28) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020475s021lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869943560057812, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=Kircik LH, Draelos ZD, Berson DS. Polymeric emulsion technology applied to tretinoin[J]. J Drugs Dermatol, 2019, 18(4): 148-154., articleTitle=null, refAbstract=null), Reference(id=1329869943622972373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=Singhvi G, Manchanda P, Hans N,
et al. Microsponge: an emerging drug delivery strategy[J]. Drug Dev Res, 2019, 80(2): 200-208., articleTitle=null, refAbstract=null), Reference(id=1329869943690081238, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=Eichenfield LF, Nighland M, Rossi AB,
et al. Phase 4 study to assess tretinoin pump for the treatment of facial acne[J]. J Drugs Dermatol, 2008, 7(12): 1129-1136., articleTitle=null, refAbstract=null), Reference(id=1329869943765578711, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=Galderma. Epiduo Forte
®(adapalene and benzoyl peroxide) gel 0.1%/2.5% for topical use: US prescribing information[EB/OL]. (2015-07-15) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207917Orig1s000Lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869943841076184, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=涂平, 季素珍, 李冠群, 等. 阿达帕林凝胶治疗寻常痤疮疗效观察[J]. 中华皮肤科杂志, 1999, (6): 424-425., articleTitle=null, refAbstract=null), Reference(id=1329869943903990745, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=Stein Gold L, Werschler WP, Mohawk J. Adapalene/benzoyl peroxide gel 0.3%/2.5%: effective acne therapy regardless of age or gender[J]. J Drugs Dermatol, 2017, 16(6): 582-589., articleTitle=null, refAbstract=null), Reference(id=1329869943962711002, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=Almirall. Aczone
®(dapsone) gel 7.5% for topical use: US prescribing information[EB/OL]. (2016-02-24) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/207154Orig1s000Lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869944021431259, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=Al-Salama ZT, Deeks ED. Dapsone 7.5% gel: a review in acne vulgaris[J]. Am J Clin Dermatol, 2017, 18(1): 139-145., articleTitle=null, refAbstract=null), Reference(id=1329869944080151516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=杨德刚, 史玉玲. 氨苯砜在皮肤科的应用进展[J]. 皮肤科学通报, 2021, 38(4): 364-369., articleTitle=null, refAbstract=null), Reference(id=1329869944143066077, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=Thiboutot DM, Kircik L, Mcmichael A,
et al. Efficacy, safety, and dermal tolerability of dapsone gel, 7.5% in patients with moderate acne vulgaris: a pooled analysis of two phase 3 trials[J]. J Clin Aesthet Dermatol, 2016, 9(10): 18-27., articleTitle=null, refAbstract=null), Reference(id=1329869944210174942, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=Smith JA, Narahari S, Hill D,
et al. Tazarotene foam, 0.1%, for the treatment of acne[J]. Expert Opin Drug Saf, 2016, 15(1): 99-103., articleTitle=null, refAbstract=null), Reference(id=1329869944281478111, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=Stiefel Laboratories. Fabior
®(tazarotene) foam 0.1% for topical use: US prescribing information[EB/OL]. (2012-05-11) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202428lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869944340198368, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[63], rfOrder=62, authorNames=null, journalName=null, refType=null, unstructuredReference=Gregoriou S, Kritsotaki E, Katoulis A,
et al. Use of tazarotene foam for the treatment of acne vulgaris[J]. Clin Cosmet Investig Dermatol, 2014, 7: 165-170., articleTitle=null, refAbstract=null), Reference(id=1329869944407307233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[64], rfOrder=63, authorNames=null, journalName=null, refType=null, unstructuredReference=Foamix. Amzeeq
®(minocycline) foam 4% for topical use: US prescribing information[EB/OL]. (2019-10-18) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212379Orig1s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869944482804706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[65], rfOrder=64, authorNames=null, journalName=null, refType=null, unstructuredReference=Paik J. Topical minocycline foam 4%: a review in acne vulgaris[J]. Am J Clin Dermatol, 2020, 21(3): 449-456., articleTitle=null, refAbstract=null), Reference(id=1329869944549913571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[66], rfOrder=65, authorNames=null, journalName=null, refType=null, unstructuredReference=Gold LS, Del Rosso JQ, Kircik L,
et al. Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: results of 2 phase 3, randomized, clinical trials[J]. J Am Acad Dermatol, 2020, 82(5): 1166-1173., articleTitle=null, refAbstract=null), Reference(id=1329869944612828132, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[67], rfOrder=66, authorNames=null, journalName=null, refType=null, unstructuredReference=Almirall. Seysara
®(sarecycline) tablet 60 mg/100 mg/150 mg for oral use: US prescribing information[EB/OL]. (2019-10-18) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/209521Orig1s000Lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869944684131301, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[68], rfOrder=67, authorNames=null, journalName=null, refType=null, unstructuredReference=Deeks ED. Sarecycline: first global approval[J]. Drugs, 2019, 79(3): 325-329., articleTitle=null, refAbstract=null), Reference(id=1329869944742851558, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[69], rfOrder=68, authorNames=null, journalName=null, refType=null, unstructuredReference=李素君, 白秋江. 治疗痤疮新药sarecycline概述[J]. 药物流行病学杂志, 2019, 28(9): 620-623., articleTitle=null, refAbstract=null), Reference(id=1329869944805766119, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[70], rfOrder=69, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun Pharma. Absorica
®(isotretinoin) capsule 10 mg/20 mg/25 mg/30 mg/35 mg/40 mg for oral use: US prescribing information[EB/OL]. (2019-11-07) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021951s013lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869944881263592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[71], rfOrder=70, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun Pharma. Absorica LD
®(isotretinoin) capsule 8 mg/16 mg/20 mg/24 mg/28 mg/32 mg for oral use: US prescribing information[EB/OL]. (2019-11-05) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211913lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869944969343977, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[72], rfOrder=71, authorNames=null, journalName=null, refType=null, unstructuredReference=Jones M, Armstrong AW, Baldwin H,
et al. Article: advances in oral isotretinoin therapy[J]. J Drugs Dermatol, 2021, 20(5): s5-s11., articleTitle=null, refAbstract=null), Reference(id=1329869945040647146, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[73], rfOrder=72, authorNames=null, journalName=null, refType=null, unstructuredReference=Cinar SL, Kartal D, Aksoy H,
et al. Long-term effect of systemic isotretinoin on female fertility[J]. Cutan Ocul Toxicol, 2017, 36(2): 132-134., articleTitle=null, refAbstract=null), Reference(id=1329869945124533227, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[74], rfOrder=73, authorNames=null, journalName=null, refType=null, unstructuredReference=Journey Medical. Ximino
®(minocycline hydrochloride) capsule 45 mg/67.5 mg/90 mg/112.5 mg/135 mg for oral use: US prescribing information[EB/OL]. (2012-07-11) [2022-01-05]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201922s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329869945208419308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[75], rfOrder=74, authorNames=null, journalName=null, refType=null, unstructuredReference=Torok HM. Extended-release formulation of minocycline in the treatment of moderate-to-severe acne vulgaris in patients over the age of 12 years[J]. J Clin Aesthet Dermatol, 2013, 6(7): 19-22., articleTitle=null, refAbstract=null), Reference(id=1329869945271333869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[76], rfOrder=75, authorNames=null, journalName=null, refType=null, unstructuredReference=Markert C, Thoma G, Srinivas H,
et al. Discovery of LYS006, a potent and highly selective inhibitor of leukotriene A(4) hydrolase[J]. J Med Chem, 2021, 64(4): 1889-1903., articleTitle=null, refAbstract=null), Reference(id=1329869945325859823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[77], rfOrder=76, authorNames=null, journalName=null, refType=null, unstructuredReference=Kelhälä HL, Palatsi R, Fyhrquist N,
et al. IL-17/Th17 pathway is activated in acne lesions[J]. PLoS ONE, 2014, 9(8): e105238., articleTitle=null, refAbstract=null), Reference(id=1329869945392968688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[78], rfOrder=77, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun J, Fan Y, Ye W,
et al. Near-infrared light triggered photodynamic and nitric oxide synergistic antibacterial nanocomposite membrane[J]. Chem Eng J, 2021, 417(1): 128049., articleTitle=null, refAbstract=null), Reference(id=1329869945472660465, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[79], rfOrder=78, authorNames=null, journalName=null, refType=null, unstructuredReference=Ramos Campos EV, Proença PLF, Doretto-Silva L,
et al. Trends in nanoformulations for atopic dermatitis treatment[J]. Expert Opin Drug Deliv, 2020, 17(11): 1615-1630., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329869939143455627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, xref=null, ext=[AuthorCompanyExt(id=1329869939147649932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, companyId=1329869939143455627, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1329869939156038541, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869938552058760, companyId=1329869939143455627, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.04.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.04.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.04.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.04.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1681056000000, fullTextJson=null, articleText=null, reference=null)